Press release
Susan Schniepp, VP of Quality at OSO BioPharmaceuticals, Elected to PDA Board of Directors
ALBUQUERQUE, N.M. – Susan Schniepp, vice president of quality at OSO BioPharmaceuticals Manufacturing, LLC, has been elected to the board of directors at the Parenteral Drug Association (PDA).Schniepp has enjoyed a long and productive relationship with the PDA. In addition to serving on numerous committees and being a featured speaker at events, she received the PDA’s Distinguished Author Award for her book, Understanding the United States Pharmacopeia and the National Formulary: Demystifying the Standards-Setting Process.
Schniepp also received the PDA’s Distinguished Service Award in 2008 and its Gordon Personeus Award in 2010, which honors a long-time member for noteworthy contributions to the organization.
“Sue is a shining star within our industry for her unflagging commitment to high quality and her willingness to share her knowledge and experience with others,” said Stuart Rose, president and CEO of OsoBio. “Serving on the PDA board affords Susan yet another opportunity to spread the quality message and lead by example.”
In managing all operational quality-related issues for OsoBio, Schniepp is responsible for cGMP compliance of facilities. Quality-related matters concerning validation as well as regulatory affairs, records and filings also fall under her scope of responsibility.
Recently, Schniepp served as chairwoman of the Monograph Development–Psychiatrics and Psychoactives Expert Committee for United States Pharmacopeia (USP), a non–governmental, official public standards–setting authority for prescription and over–the–counter medicines and other health-care products manufactured or sold in the United States. USP standards for quality, purity, strength and consistency are recognized and used in more than 130 countries.
As the first woman appointed to serve on the editorial advisory board of Pharmaceutical Technology magazine, Schniepp writes the publication’s quarterly column, “Inside Standards.”
Schniepp’s term on the PDA board of directors is for two years.
PDA was founded in 1946 by a small group of pharmaceutical manufacturers who recognized the need to disseminate technical information within the industry. Today, with more than 10,000 members worldwide, PDA is the recognized authoritative voice and leading technical organization in the field of parenteral science and technology.
OSO BioPharmaceuticals Manufacturing, LLC, is a contract manufacturing organization (CMO) focusing on biologic and pharmaceutical injectables.
Headquartered in Albuquerque, N.M., OsoBio specializes in products requiring complex handling, including highly potent compounds. Responsiveness, attention to detail and clear communication are the hallmarks of our client care.
OsoBio surpasses quality-assurance expectations within our industry. Our employees are industry veterans who provide innovative solutions to our clients’ most difficult projects.
# # #
CONTACT: Milton Boyer, VP business development and sales, 706.694.2514
OSO BioPharmaceuticals Manufacturing, LLC, is a contract manufacturing organization (CMO) focusing on biologic and pharmaceutical injectables.
Karen Stinneford
Sinclair & Co.
619 Oberlin Road, Suite 200
Raleigh, NC 27605
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Susan Schniepp, VP of Quality at OSO BioPharmaceuticals, Elected to PDA Board of Directors here
News-ID: 160060 • Views: …
More Releases from Oso BioPharmaceuticals Manufacturing, LLC
Tracking Environmental Monitoring Trends Crucial to Regulatory Compliance, OsoBi …
ALBUQUERQUE, N.M. – A microbiology laboratory manager at OSO BioPharmaceuticals Manufacturing, LLC, has authored a chapter on environmental monitoring trends for an industry reference manual.
Kim Van Antwerpen wrote a chapter for “Environmental Monitoring: A Comprehensive Handbook (vol. 5)” edited by Jeanne Moldenhauer and being published in September by the Parenteral Drug Association.
Van Antwerpen’s key observation is that aseptic drug manufacturers should closely observe the environmental monitoring trends of their…
OSO BioPharmaceuticals Manufacturing LLC Honored for Corporate Efforts to Protec …
ALBUQUERQUE, N.M. – OSO BioPharmaceuticals Manufacturing, LLC, has received the Pollution Prevention Award for its efforts to protect water quality in the Rio Grande River.
The honor was awarded by the Albuquerque Bernalillo County Water Utility as part of its Pollution Prevention Program (P2 Program).
The P2 Program was created in 1992 to protect Albuquerque’s water treatment plant and the Rio Grande River from harmful waste runoff. The program recognizes businesses for…
More Releases for PDA
PDA Occluder System Market Outlook and Future Projections for 2030
The pda occluder system market represents a dynamic and continually evolving landscape, shaped by changing consumer demands and technological advancements. In this comprehensive report, we provide an in-depth exploration of the market, designed for a wide range of stakeholders including manufacturers, suppliers, distributors, and investors. Our goal is to equip industry participants with essential insights that enable informed decision-making in an ever-changing market environment. This analysis not only examines the…
PDA Terminal Market 2024: A Decade of Phenomenal Growth Ahead
The PDA Terminal Market 2024-2023 report provides a comprehensive analysis of Types (PDA Barcode Scanner, PDA RFID Reader), Application (Retail and Wholesale, Logistics and Warehousing, Industrial Manufacturing, Healthcare, Government, Others), Analysis of Industry Trends, Growth, and Opportunities, R&D landscape, Data security and privacy concerns Risk Analysis, Pipeline Products, Assumptions, Research Timelines, Secondary Research and Primary Research, Key Insights from Industry Experts, Regional Outlook and Forecast, 2024-2032.
Major Players of PDA Terminal Market…
Multifunctional Industrial RFID PDA for Efficiency improvement in Mobile Mainten …
Moers, 01.09.2011 Using rugged PDAs with RFID support is already common in the modern maintenance application and in the logistics supply chain (permanent inventory and object checking and technical inspection) as well. The requirement in multi-functionality has increased as well because people who are used to use mobile smartphones daily by taking pictures and send these by email or mms or Bluetooth to other people or to host systems.…
PDA Marketing Receives Certification as a Small Business Enterprise
PDA Marketing, in Baltimore, Maryland, was recently certified as a Small Business Enterprise by the state of Maryland. This recognition follows closely behind their recertification as both a MBE/DBE and WBE business. PDA specializes in online and offline marketing. Their services include web development, search engine optimization, social media marketing, direct mail, creative services, and sale management. The nationally acclaimed Deliver magazine featured PDA Marketing’s direct…
PDA Marketing Certified as MBE/DBE and WBE--Business
PDA Marketing has recently been recertified as both a Minority Business Enterprise (MBE) and a Disadvantaged Business Enterprise (DBE) by the Maryland Department of Transportation. To be certified as a MBE, more than 51% of the owner(s) of the business must fall into one of the United State’s minority groups. Over half of those managing the regular business of the company must also be in a minority group.…
MetricStream to Exhibit at 2008 PDA Annual Meeting
MetricStream, Inc., the market leader in enterprise-wide Governance, Risk, Compliance (GRC) and Quality Management solutions, today announced that it is participating in the 2008 Annual Meeting of the Parenteral Drug Association (PDA). PDA is a nonprofit organization and a leading global provider of science, technology and regulatory information and education for the pharmaceutical and biopharmaceutical community. MetricStream will demonstrate its industry leading solutions for quality, compliance and risk management…